-
Keros Therapeutics (NASDAQ:KROS) Receives Buy Rating from HC Wainwright
ソース: Buzz FX / 07 11 2024 09:26:16 America/New_York
Keros Therapeutics (NASDAQ:KROS) Receives Buy Rating from HC Wainwright Written by MarketBeat November 7, 2024 Share Link copied to clipboard. Keros Therapeutics ( NASDAQ:KROS - Get Free Report ) 's stock had its "buy" rating reissued by eq
Read more...